Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said Wednesday.
Search Results for: label/Flowserve – Page 3
Tantalum, courtesy of Enough Project via YouTubeThe federal appeals court for the D.C. circuit issued its opinion Monday in National Association of Manufacturers (NAM), et al., v. Securities and Exchange Commission that partially struck down the SEC’s conflict minerals disclosure rule.
Law firm Hughes Hubbard & Reed, a sponsor of the FCPA Blog, has released its FCPA/Anti-Bribery Mid-Year Alert 2010. The authors say it’s both a quick desk reference and — at 241 pages — an authoritative collection of FCPA resources. They’re right. There’s exhaustive enforcement-related information — DOJ and SEC actions, DOJ opinion procedure releases, […]
While looking at FCPA enforcement data, Bruce Hinchey, left, made a startling and disturbing discovery about the consequences of self reporting. Here’s his story: * * * Dear FCPA Blog, Many question the Department of Justice’s claim that there are tangible benefits to voluntary disclosure of a FCPA violation. As a part of a yet […]
The Justice Department on Monday described BAE’s $400 million FCPA-related settlement as one of the biggest ever. Here, by our reckoning, are the other big payouts: Siemens’ $800 million resolution with the DOJ and SEC in December 2008 is the most expensive so far. Kellogg Brown & Root and Halliburton settled their case last year […]